FLNA

Filana Therapeutics Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 5/10
  • Value↑ 9/10
Filana Therapeutics sales and earnings growth
FLNA Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -254.72%
  • FCF Y/Y↑ 71.95%
Filana Therapeutics gross and profit margin trends
FLNA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 719.99%
Filana Therapeutics net debt vs free cash flow
FLNA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Filana Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks